Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Keynote lecture: Mutation signatures and targeting the DNA damage response

Prof Thomas Helleday - Sheffield Cancer Centre, Sheffield, UK
Keynote lecture: Mutation signatures and targeting the DNA damage response ( Prof Thomas Helleday - Sheffield Cancer Centre, Sheffield, UK )
29 Oct 2018

Dosing regiment in the combination of ipilimumab and nivolumab in stage III melanoma

Dr Lisette Rozeman - Netherlands Cancer Institute, Amsterdam, Netherlands
Dosing regiment in the combination of ipilimumab and nivolumab in stage III melanoma ( Dr Lisette Rozeman - Netherlands Cancer Institute, Amsterdam, Netherlands )
29 Oct 2018

COLUMBUS: Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma

Prof Dirk Schadendorf - Uniklinik Essen, Essen, Germany
COLUMBUS: Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma ( Prof Dirk Schadendorf - Uniklinik Essen, Essen, Germany )
29 Oct 2018

Latest advances in treatment for ALK positive NSCLC

Prof Gordon McVie, Dr Lázaro Quintela
Latest advances in treatment for ALK positive NSCLC ( Prof Gordon McVie, Dr Lázaro Quintela )
26 Oct 2018

The case for biosimilars

Dr Hans-Christian Kolberg - Marienhospital, Bottrop, Germany
The case for biosimilars ( Dr Hans-Christian Kolberg - Marienhospital, Bottrop, Germany )
26 Oct 2018

Highlights in early non-metastatic NSCLC and thoracic tumours

Dr Enriqueta Felip - Vall d'Hebron University Hospital (VHIO), Barcelona, Spain
Highlights in early non-metastatic NSCLC and thoracic tumours ( Dr Enriqueta Felip - Vall d'Hebron University Hospital (VHIO), Barcelona, Spain )
26 Oct 2018

Highlights in SCLC from ESMO 2018

Dr Noemi Reguart - University of Barcelona, Barcelona, Spain
Highlights in SCLC from ESMO 2018 ( Dr Noemi Reguart - University of Barcelona, Barcelona, Spain )
26 Oct 2018

Safety analysis of entrectinib for NTRK fusion tumours

Dr George D. Demetri - Harvard Cancer Center, Boston, USA
Safety analysis of entrectinib for NTRK fusion tumours ( Dr George D. Demetri - Harvard Cancer Center, Boston, USA )
26 Oct 2018

TRITON2: Evaluation of rucaparib in patients with metastatic castration-resistant prostate cancer

Dr Josep Piulats - IDIBELL, Barcelona, Spain
TRITON2: Evaluation of rucaparib in patients with metastatic castration-resistant prostate cancer ( Dr Josep Piulats - IDIBELL, Barcelona, Spain )
26 Oct 2018

ASCEND-8: safety data of ceritinib with or without food in NSCLC

Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, Republic of Korea
ASCEND-8: safety data of ceritinib with or without food in NSCLC ( Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, Republic of Korea )
26 Oct 2018

CheckMate142: Checkpoint combination therapy in first-line colorectal cancer

Dr Heinz-Josef J. Lenz - Keck School of Medicine of USC, Los Angeles, USA
CheckMate142: Checkpoint combination therapy in first-line colorectal cancer ( Dr Heinz-Josef J. Lenz - Keck School of Medicine of USC, Los Angeles, USA )
26 Oct 2018

SOLO1: Maintenance olaparib in advanced BRCA ovarian cancer

Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA
SOLO1: Maintenance olaparib in advanced BRCA ovarian cancer ( Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA )
26 Oct 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation